Evidence map›Paper›PMID 28408459›Full record

ArticleBlood2017

EPCR expression marks UM171-expanded CD34

Iman Fares, Jalila Chagraoui, Bernhard Lehnertz, Tara MacRae, Nadine Mayotte, Elisa Tomellini, Léo Aubert, Philippe P Roux, Guy Sauvageau

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 219 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expression.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Ex Vivo Expansion of Cord Blood Hematopoietic Stem and Progenitor Cells.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Iman FaresMolecular Genetics of Stem Cells Laboratory.
Jalila ChagraouiMolecular Genetics of Stem Cells Laboratory.
Bernhard LehnertzMolecular Genetics of Stem Cells Laboratory.
Tara MacRaeMolecular Genetics of Stem Cells Laboratory.
Nadine MayotteMolecular Genetics of Stem Cells Laboratory.
Elisa TomelliniMolecular Genetics of Stem Cells Laboratory.
Léo AubertCell Signalling and Proteomics Research Unit, Institute of Research in Immunology and Cancer, and.
Philippe P RouxCell Signalling and Proteomics Research Unit, Institute of Research in Immunology and Cancer, and.
Guy SauvageauMolecular Genetics of Stem Cells Laboratory.
Hôpital Maisonneuve-Rosemont · CAInstitute for Research in Immunology and Cancer · CAUniversité de Montréal · CA

Funding

CIHR
6 · The paper itself

Abstract

A small subset of human cord blood CD34

Indexed as

AnimalsAntigens, CDAntigens, CD34Cell Culture TechniquesCell ProliferationEndothelial Protein C ReceptorFemaleFetal BloodHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansIndolesMice, Inbred NODMice, SCIDPyrimidinesReceptors, Cell SurfaceAntigens, CDAntigens, CD34Endothelial Protein C ReceptorIndolesPROCR protein, humanPyrimidinesReceptors, Cell SurfaceUM171 compound

Identifiers

PMID28408459
OpenAlexW2607410024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.